Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?

Optometry and vision science : official publication of the American Academy of Optometry - 1 Mar 2018

McCarty Catherine A, Fuchs Michael J, Lamb Allan, Conway Pat

Abstract excerpt

SIGNIFICANCE: The American Academy of Ophthalmology currently recommends against routine genetic testing for complex diseases such as age-related macular degeneration (AMD). The results of this study demonstrate that patients are very interested in predictive genetic testing for AMD, find the information useful, and make behavioral changes as a result of the information. PURPOSE: The goal of this project was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement C3
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Macular Degeneration

Share to NADH Dehydrogenase

Share to Patients

Share to Pilot Projects

Share to Proteins

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 29424826
DOI: 10.1097/OPX.0000000000001188
PMCID: PMC5839714

Genes

CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?PMID 29424826Read ↗

Genetics of age-related macular degeneration (AMD)Semantic proximity Read ↗

Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response.Semantic proximity Read ↗

Direct-to-consumer personal genome testing for age-related macular degeneration.Semantic proximity Read ↗

Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.Semantic proximity Read ↗

Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.Semantic proximity Read ↗

Limitations of direct-to-consumer genetic testing for age-related macular degeneration.Semantic proximity Read ↗

The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).Semantic proximity Read ↗

Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration.Semantic proximity Read ↗

Genetic testing for age-related macular degeneration: not indicated now.Semantic proximity Read ↗

Assessing individual risk for AMD with genetic counseling, family history, and genetic testing.Semantic proximity Read ↗

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).Semantic proximity Read ↗

Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.